Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
Einband grossDrug Control and International Law
ISBN/GTIN

Drug Control and International Law

E-BookPDFDRM AdobeE-Book
244 Seiten
Englisch
Taylor & Franciserschienen am08.10.20181. Auflage
The book provides for an extensive legal analysis of the international drug control system in the light of growing challenges and criticism that this system faces. It provides an in-depth and positivist insight into drug control's present legal framework.mehr
Verfügbare Formate
BuchGebunden
EUR182,50
TaschenbuchKartoniert, Paperback
EUR57,50
E-BookEPUBDRM AdobeE-Book
EUR53,99
E-BookPDFDRM AdobeE-Book
EUR53,99

Produkt

KlappentextThe book provides for an extensive legal analysis of the international drug control system in the light of growing challenges and criticism that this system faces. It provides an in-depth and positivist insight into drug control's present legal framework.
Details
Weitere ISBN/GTIN9781351047111
ProduktartE-Book
EinbandartE-Book
FormatPDF
Format HinweisDRM Adobe
Erscheinungsjahr2018
Erscheinungsdatum08.10.2018
Auflage1. Auflage
ReiheRoutledge Research in International Law
Seiten244 Seiten
SpracheEnglisch
Dateigrösse3436 Kbytes
Illustrationen1 schwarz-weiße Tabellen
Artikel-Nr.4385264
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
Acknowledgments

List of abbreviations

1 Introduction

1.1 International drug control after UNGASS 2016: more of the same or towards a fundamental turning point?

1.2 Objectives and methodology of this book

2 The sources and actors of the international drug control system

2.1 The primary sources of the international drug control system

2.2 The institutions of the international drug control system and a typology of their secondary instruments

2.3 Conclusion

3 The emergence of the international drug control system

3.1 Towards one coherent obligation to confine drugs to medical and scientific purposes

3.2 A constant expansion of the international drug control system

3.3 The international drug control system as a prime example of the law of cooperation

3.4 Conclusion

4 The objective of the international drug control system: limitation of drugs to medical and scientific purposes

4.1 The need to understand the limitation of drugs to medical and scientific purposes

4.2 The meaning of the limitation of all drug-related activities to medical and scientific purposes

4.3 Exceptions to the limitation of drugs to medical and scientific purposes within the international drug control system

4.4 Options to deviate from the limitation of drugs to medical and scientific purposes in the international drug control system

4.5 Does international human rights law conflict with the limitation of drugs to medical and scientific purposes?

4.6 Conclusion

5 The material scope of the international drug control system

5.1 Substances limited to medical and scientific purposes

5.2 Modification of the scope of application of the international drug control system (scheduling)

5.3 Prospects for exempting cannabis and the coca leaf from drug control's scope of application

5.4 The challenge of regulating uncertainty: the rise of new psychoactive substances and the international drug control system

5.5 Conclusion

6 Challenges to the implementation of the international drug control system

6.1 Control of the licit supply chain: achieving a balance between limiting and ensuring an adequate availability of drug supply?

6.2 Suppression of illicit supply: the UN Drug Conventions as a punitive and sanction-oriented system of control?

6.3 Demand-reduction obligations providing for a human- and health-oriented treatment of drug users?

6.4 Fairness and the premise of the international drug control system to limit drugs to medical and scientific purposes by relying on a control of drug supply

6.5 Conclusion

7 Concluding remarks and outlook

Bibliography

Indexmehr

Autor

Daniel Wisehart is an associate at Wach + Meckes LLP, Munich. He has previously worked as a researcher at the Universität Potsdam and the Universität Freiburg and clerked for the European Court of Human Rights.
Weitere Artikel von
Wisehart, Daniel